Form 4: Tarsus Pharmaceuticals Director Scott W. Morrison Acquires Stock Options and Restricted Stock Units

Director Scott W. Morrison acquired stock options and restricted stock units in Tarsus Pharmaceuticals, Inc. related to his service as a non-employee director.

Summary

• On June 13, 2024, Scott W. Morrison, a director of Tarsus Pharmaceuticals, Inc., acquired stock options and restricted stock units (RSUs).
• Morrison received options to purchase 5,000 shares of common stock at an exercise price of $33.14, vesting fully on June 12, 2025.
• He also received 3,350 RSUs, each representing a contingent right to receive one share of the company's common stock, vesting fully on June 13, 2025.
• These grants are related to Morrison's service as a non-employee director as of the company's 2024 annual meeting of stockholders.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, indicating a stable and ongoing relationship between the director and the company. This is generally viewed as a neutral to slightly positive signal.

Positives

• The acquisition of stock options and RSUs by a director signals confidence in the company's future performance.
• The vesting schedules incentivize the director to remain engaged with the company.

Future Outlook

The document does not contain specific forward-looking statements, but the equity grants suggest an expectation of continued service and contribution from the director.

Industry Context

Equity compensation is a common practice for directors of publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages typically include a mix of cash and equity.
• The size and structure of the equity grants are generally benchmarked against peer companies to attract and retain qualified board members.
• Companies like Alcon, Bausch + Lomb, and Johnson & Johnson also use stock options and RSUs as part of their director compensation packages.

Stakeholder Impact

• The equity grants align the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Key Dates